Linda Cutter / Dr Charles Heatley. GP Practices and Community Pharmacies

Size: px
Start display at page:

Download "Linda Cutter / Dr Charles Heatley. GP Practices and Community Pharmacies"

Transcription

1 Schedule 2 Part A Service Specification Service Specification No. 04 Service Anti-coagulation Monitoring Levels 3, 4 & 5 Commissioner Lead Provider Lead Linda Cutter / Dr Charles Heatley GP Practices and Community Pharmacies Period April 2017 March 2018 Date of Review September Population Needs 1.1 National/local context and evidence base Warfarin is being used in the management of increasing numbers of patients and conditions including patients with atrial fibrillation, DVTs and other disorders. While it is a very effective drug in these conditions, it can also have serious side effects, e.g. severe haemorrhage. These side effects are related to the International Normalised Ratio (INR) level, which measures the delay in the clotting of the blood caused by the warfarin. While the normal INR is 1, the specific range of INR values depends on the disease and the clinical conditions. Warfarin monitoring aims to stabilise the INR within set limits to help prevent serious side-effects while maximising effective treatment. 2. Outcomes 2.1 NHS Outcomes Framework Domains & Indicators Domain 1 Domain 2 Domain 3 Domain 4 Domain 5 Preventing people from dying prematurely Enhancing quality of life for people with long-term conditions Helping people to recover from episodes of ill-health or following injury Ensuring people have a positive experience of care Treating and caring for people in safe environment and protecting them from avoidable harm X x X 2.2 Local defined outcomes Outcome Patient care closer to home Improved patient choice Reduction in secondary care activity. Demonstrated by Patients receiving treatment at a site locally convenient to them. Patient has the option to be seen at a site locally convenient to them. Patients managed in primary care where appropriate. 1

2 3. Scope 3.1 Aims and objectives of service An anticoagulation monitoring service is designed to be one in which: i. Patients will usually be initiated on warfarin in a secondary care setting though many practices will be happy to initiate therapy for patients identified as having atrial fibrillation. Where warfarin treatment is initiated in secondary care for recognised indications for specified lengths of time, there is a recognised mechanism for safe transfer of care between secondary and primary care providers; ii. The patients INR should be controlled within the agreed range; iii. The service to the patient is convenient; iv. The need for continuation of therapy is reviewed regularly and discontinued when appropriate; v. Patients with atrial fibrillation who have sub-optimal INR control (see unstable anticoagulation criteria below) are considered for one of the newer direct acting oral anticoagulants (NOACs or DOACs) Unstable anticoagulation criteria (NICE CG180) Any one of: 2 INRs >5 in the last 6 months 1 INR >8 in the last 6 months 2 INRs <1.5 in the last 6 months (without planned interruptions) Time in therapeutic range <65% 3.2 Service description/care pathway The provider delivering this LCS will be expected to comply with these recommendations; i. Patient register. The provider is required to maintain a register of all patients on warfarin and as a minimum this should reference the clinical reason for warfarinisation. It is recommended that the target INR is captured in the clinical record. Where any patients are not monitored by the practice the patient clinical record clearly states who is responsible, and should show evidence that appropriate monitoring is taking place. Read codes for secondary care monitoring are: Anticoagulation monitoring secondary care XaL3h (SystmOne) Anticoagulation monitoring secondary care - 66QC (EMIS Web) The register for patients being monitored by the provider will include, where applicable: The patient s name and date of birth; The indication for and duration of treatment; Computerised linkage of medication to indication for treatment; Target INR must be recorded; Relevant clinical history, examination findings and test results; Read codes for monitoring: 2

3 SystmOne Read codes are as follows; Anticoagulation monitoring in primary care XaMh8 Home visit for anticoagulation monitoring XaQyK Self monitoring of INR XaNbr ii. EMIS Web read codes are as follows: Anticoagulation monitoring - primary care - 66QD Home visit for anticoagulation monitoring - primary care - 9K27 Self monitoring of INR - 66QE Follow up arrangements (should include including evidence of a robust call and recall system ). The above entries must be recorded in both the patients electronic clinical record (for GP practices) as well as in the Clinical Decision Support Software (CDSS). CDSS. All providers must use an appropriate Clinical Decision Support System (CDSS) and are advised to use the web based INRstar, as approved by Sheffield CCG. Level 1A evidence from the British Committee for Standards in Haematology guidelines on oral anticoagulation with warfarin (2011) states that computer-assisted dosing is superior to manual dosing for patients on warfarin. The costs for the CDSS are built into the per patient payment. Providers may opt to use other approved CDSS but where this is more expensive only the equivalent costs of INRstar are incorporated into the payment fee. Providers are responsible for ensuring all appropriate licences are in place, dependant on the level of service being provided and licences are kept up to date. iii. Meters. For those providers undertaking INR testing at level 4, the meters used should meet the agreed standards for medical devices. Most providers are using Roche meters and are encouraged to use the CoaguChek XS Plus meter. Roche will provide training on use and, in addition, have agreed a cluster based discount for Sheffield providers purchasing the testing strips. Testing strips must not be prescribed on FP10, except for patients who are self-monitoring. Where patients have bought their own meters and the provider is giving dosing advice and guidance, the provider is required to ensure that the patient is using the meter correctly; check against a venous sample or quality control test on at least an annual basis; these patients should be classed as Level 3. iv. Call and recall. To ensure that systematic call and recall is in place for patients being monitored by the provider. v. Professional links. To work together with other professionals where appropriate. Any health professionals involved in the care of patients should be appropriately trained. vi. Referral policies. When appropriate, to refer patients promptly to other necessary services and to the relevant support agencies, using locally agreed guidelines where these exist. vii. Education. To ensure education of patients (and/or their carers and support staff where appropriate) regarding their warfarin therapy, including the provision of a patient-held booklet. The NPSA patient information booklet should be used. 3

4 viii. Individual management plans. To prepare with the patient an individual management plan which gives the diagnosis, planned duration and therapeutic range to be obtained (e.g. the yellow book). ix. Clinical procedures. To ensure that at initial diagnosis, and at least annually, an appropriate review of the patient s health is carried out. This includes checking for potential complications and a review of the patient s monitoring records. To ensure that all clinical information relating to the LCS is recorded in the electronic patient record. x. Record keeping. To maintain adequate records, using the CDSS, to evaluate the performance and result of the service provided. This should include the number of bleeding episodes requiring hospital admission and deaths caused by anticoagulants. xi. Initiation (level 5 provision). Where the service is provided by a GP, they may initiate warfarin for thromboprophylaxis in atrial fibrillation. This is an optional element of the service for which a separate one-off payment is made, to cover the costs of the additional consultations required to stabilise the patient. The dosing guidelines to be followed for initiation are included in the Sheffield CCG s Anticoagulation Monitoring Service Standard Operating Procedure xii. NPSA Alert. The National Patient Safety Agency has issued guidance that must be used in conjunction with this specification. ac xiii. Clinical Audit. All providers must agree to Sheffield CCG accessing provider level data through INRstar Analytics on at least a quarterly basis; this is for clinical audit and quality improvement purposes as detailed in schedule 4 part c. Individual provider data and anonymised reports will be sent to providers. Providers will be asked to complete an action plan based on data extracted from INRstar Analytics. Outcomes of audits and data taken at the end of each quarter from INRstar Analytics may be discussed with providers. The Clinical Audit and Effectiveness Team may request action plans from providers on how recommendations have been implemented from provider based data extracted by INRstar Analytics. If providers are not using INRstar it will still be a requirement to provide the data requested by the Clinical Audit and Effectiveness Team. xiv. Consent to access provider data. By signing this contract providers are agreeing to Sheffield CCG accessing non-patient identifiable information via the INRstar Analytics computer system. xv. National External Quality Assurance Scheme (NEQAS). Sheffield CCG requires providers using near patient testing equipment to participate in the web based NEQAS. The cost for this is incorporated in the per patient payment. Providers are responsible for ensuring subscriptions are in place and are kept up to date; xvi. Accreditation/Training. Doctors, pharmacists and nurses new to providing an anticoagulation monitoring service must attend an approved course as detailed in the anticoagulation SOP. Doctors shall be deemed professionally qualified to contract for the locally commissioned service if they have: previously provided an anticoagulation monitoring service similar to this service; and have the necessary continuing medical experience, training and competency. All providers must ensure that all clinicians involved in providing the service have also received training to use the CDSS. xvii. Dosing. The doser is a registered health care professional who is suitable trained and competent in anticoagulation management. The dose of warfarin will be determined upon receipt of the INR results from the laboratories or near-patient testing equipment guided by the CDSS. Any dosing decisions to be documented within the electronic patient record and within the patients hand held record. 4

5 xviii. Indemnity cover. Providers are responsible for ensuring that the appropriate indemnity insurance is in place to cover all members of staff involved in service delivery. The service provider s indemnity insurance must cover HCAs, dispensers and all health-care professionals for the role they are operating with regards to anticoagulation monitoring. The Anticoagulation Monitoring Service Standing Operating Procedure (SOP) can be referred to for clarification of staff roles and responsibilities. xix. Inter Provider Referrals. Where the service is provided by someone other than the patient s own GP, the procedures as detailed in the Anticoagulation Monitoring Service SOP must be followed. 3.3 Population covered This service will be available to every patient in Sheffield eligible for primary care monitoring of anticoagulation therapy. 3.4 Any acceptance and exclusion criteria and thresholds Please see Anticoagulation Monitoring Service SOP Interdependence with other services/providers Therapy should normally be initiated in secondary care, for recognised indications for specified lengths of time. There is a recognized mechanism for safe transfer of care between secondary and primary care providers. Please refer to the Anticoagulation Monitoring Service SOP Applicable Service Standards 4.1 Applicable national standards (e.g. NICE) 4.2 Applicable standards set out in Guidance and/or issued by a competent body (e.g. Royal Colleges) 4.3 Applicable local standards 5. Location of Provider Premises The Provider s premises are located at: Individual GP Practices and Community Pharmacies Schedule 2 Part B Indicative Activity Plan Name of Service - Anticoagulation Monitoring levels 3, 4 and 5 Xxx cumulative total of active patients reported each month (estimated number of patients is this figure / 12) 5

6 Schedule 2 Part C Activity Planning Assumptions Name of Service - Anticoagulation Monitoring levels 3 and 4 Providers are funded for a maximum of 12 home visits per patient per year for INR levels 3 & 4 only Schedule 2 Part F Clinical Networks and National Programmes Schedule 2 Part G Other Locally Agreed Policies and Procedures Policy Date Weblink Anticoagulation Monitoring Service Standard Operating Procedure October 2014 (under review) Schedule 2 Part I Exit Arrangements Schedule 2 Part K Transfer of and Discharge from Care Protocols Please refer to the Anticoagulation Monitoring Service Standard Operating Procedure ment/medicines-prescribing/prescribingguidelines.htm Schedule 3 Payment Part A Local Prices Service Description Currency Price Basis for payment Level 3 Price per per active patient month per month Level 4 Price per active patient per month Payment is per patient paid on a quarterly basis Payment is per patient paid on a Regime for future years 6

7 per month quarterly basis Level 5 Price is a Payment is per one off patient paid on a payment per quarterly basis patient initiated on warfarin for atrial fibrillation Home Visits Price per visit 6.00 Payment is per visit carried out by provider staff. A maximum of 12 visits per patient per year is permitted Please note: Additional phlebotomy costs are included at all levels. The Level 3, 4 and 5 payments are per patient (not blood tests). The Level 4 payment also includes payment for test strips and internal quality control checks. Strips must not be prescribed on FP10. Level 4 providers may opt to provide a Level 3 service to some patients where this is appropriate. Should the above circumstance arise, please inform the Contracting Team. GP providers offering a Level 3 or Level 4 service may also provide a Level 5 service. The additional payment at Level 5 is a one-off payment to cover the costs of extra consultations needed to stabilise patients and is payable only in the financial year in which warfarin is initiated. Thereafter, the normal Level 3 or 4 payment per patient will apply. Sheffield CCG will pay for home visits where completed by provider employed staff only. Payments may be subject to PPV checks and linked to audit and patients satisfaction submissions. Part B Local Variations Part F Expected Annual Contract Value Service Expected annual contract value Anticoagulation Monitoring levels 3, 4 & 5 Varies per provider see Anticoagulation Activity 7

8 Schedule 4 Part C Local Quality Requirements Quality Requirement Threshold Method of Measurement All patients should be monitored in line with: The CCG ANTICOAGULATION MONITORING SERVICE Standard Operating Procedure for the provision of a Level 3, 4 and 5 anticoagulation service The NPSA safety indicators for patients starting oral anticoagulant treatment. The NPSA safety indicators for patients established on oral anticoagulant treatment The service description/care pathway 100% Clinical Audit and effectiveness team to remotely extract audit data via INRstar Analytics and or provider submission of data The Clinical Audit and Effectiveness team may request service providers to submit action plans based on data extracted from INRstar Analytics or from provider submissions. Consequence of breach As per clause GC9 Monthly or annual application of consequence Quarterly 04 Applicable Service Specification Service providers may be required to submit evidence of indemnity cover if requested by Sheffield CCG. Schedule 4 Part F Local Incentive Scheme Schedule 5 Part B2 Provider s Permitted Material Sub-Contractors SCHEDULE 6 Part C Reporting Requirements Activity Information required Information required Reporting Period Format of Report Timing and Method for delivery of Report Number of patients Monthly As set out in the database Via LCS database by 8

9 Information required on provider register being managed at L3 & L4 Number of new initiated patients L5 Number of home visits carried out Reporting Period Format of Report Timing and Method for delivery of Report 15 th working day of the month. Monthly As set out in the database Via LCS database by 15 th working day of the month. Monthly As set out in the database Via LCS database by 15 th working day of the month. Quality Requirements Information required Information required Reporting Period Format of Report Timing and Method for delivery of Report Quality Audit Biannually Clinical Audit and effectiveness team to remotely extract audit data via INRstar Analytics or from provider submissions. Audit report to be sent out December 2017 to individual providers. Re audit report. To be sent out May Quarterly Clinical Audit and effectiveness team to remotely extract audit data via INRstar Analytics or from provider submissions. Individual provider data to be provided with areas for improvement highlighted. Providers then to use this data to inform action plans, which can be requested by Sheffield CCG. SCHEDULE 6 Part G Surveys Type of Survey Frequency Method of Reporting Method of Publication Friends and Family Test (where required in accordance with FFT Guidance) 9

10 Service User Survey Staff Surveys Carer Survey 10

Anti-Coagulation Monitoring (warfarin, acenocoumarol, phenindione) Primary Care Service (PCS:01) NHS Standard Contract Service Profile Pack ( )

Anti-Coagulation Monitoring (warfarin, acenocoumarol, phenindione) Primary Care Service (PCS:01) NHS Standard Contract Service Profile Pack ( ) Anti-Coagulation Monitoring (warfarin, acenocoumarol, phenindione) Primary Care Service (PCS:01) This pack contains: Standard Contract Service Profile Pack () 1. Service Specification: (to be inserted

More information

ANTI-COAGULATION MONITORING

ANTI-COAGULATION MONITORING ANTI-COAGULATION MONITORING 2016-17 a) Purpose of Agreement This Agreement outlines the service to be provided by the Provider, called an Anti-coagulation monitoring service. b) Duration of Agreement This

More information

Initiation of Warfarin for patients not registered with Provider Practice

Initiation of Warfarin for patients not registered with Provider Practice Initiation of Warfarin for patients not registered with Provider Practice 2017-18 1. Purpose of Agreement This Agreement outlines the service to be provided by the Provider, called Initiation of Warfarin

More information

Schedule C1. Community Pharmacy Anti-Coagulation Management Services

Schedule C1. Community Pharmacy Anti-Coagulation Management Services Schedule C1 Community Pharmacy Anti-Coagulation Management Services 1. Definition This service specification relates to the anticoagulation management of Service Users on warfarin by an accredited community

More information

Camden Clinical Commissioning Group Reporting Mechanism/Frequency Remotely/Quarterly

Camden Clinical Commissioning Group Reporting Mechanism/Frequency Remotely/Quarterly Universal Offer Service Anticoagulation - Warfarin Clinical Lead Dr Kevan Ritchie Commissioner Camden Clinical Commissioning Group Reporting Mechanism/Frequency Remotely/Quarterly Payment Frequency Quarterly

More information

SCHEDULE 2 THE SERVICES

SCHEDULE 2 THE SERVICES SCHEDULE 2 THE SERVICES A. Service Specifications 1 Introduction Anticoagulants are medicines which slow down the blood clotting process and are used to support the prevention of clot development. They

More information

Final. Andrew McMylor / Dr Nicola Jones. Jeremy Fenwick, Battersea Healthcare CIC

Final. Andrew McMylor / Dr Nicola Jones. Jeremy Fenwick, Battersea Healthcare CIC NHS Standard Contract - Service Specification Service Specification Service Commissioner Lead Lead Final Primary Care Based 12-Lead Electrocardiogram Service Andrew McMylor / Dr Nicola Jones Jeremy Fenwick,

More information

Service Specification

Service Specification Service Specification Level 4 Anticoagulation Management Release: Final Date: 1/1/11 Author: Suzanne Pickering Primary Care Commissioning Manager NHS Derbyshire County Owner: Jackie Pendleton Assistant

More information

SCHEDULE 2 THE SERVICES

SCHEDULE 2 THE SERVICES SCHEDULE 2 THE SERVICES A. Service Specifications Service Specification No. 170008/S Service Atypical haemolytic uraemic syndrome (ahus) (all ages) Commissioner Lead Provider Lead Period Date of Review

More information

Protocol for Patients on oral Anticoagulants who wish to perform INR self testing. Anticoagulation service Bolton NHS Foundation Trust. April 2017.

Protocol for Patients on oral Anticoagulants who wish to perform INR self testing. Anticoagulation service Bolton NHS Foundation Trust. April 2017. Protocol for Patients on oral Anticoagulants who Anticoagulation service Bolton NHS Foundation Trust April 2017. Document Control Document Ref No. ANTICO05 Title of document Protocol for Patient s on oral

More information

ANTICOAGULATION MONITORING SERVICE. Standard Operating Procedure For the provision of a Level 3, 4 and 5 Anticoagulation Service

ANTICOAGULATION MONITORING SERVICE. Standard Operating Procedure For the provision of a Level 3, 4 and 5 Anticoagulation Service ANTICOAGULATION MONITORING SERVICE Standard Operating Procedure For the provision of a Level 3, 4 and 5 Anticoagulation Service Version: Date at ET/PEC: September 2008 Date ratified at Board: Name and

More information

Provision of Near-Patient Testing Service. Service Level Agreement Background. 2. Financial Details

Provision of Near-Patient Testing Service. Service Level Agreement Background. 2. Financial Details Provision of Near-Patient Testing Service Service Level Agreement 2016-2019 Contents: 1. Financial Details 2. Service Aims 3. Criteria 4. Ongoing Measurement & Evaluation 5. Accreditation 1. Background

More information

Primary Care/Community Based Service Palliative Care (Just in Case Medicines) Fylde and Wyre CCG Pete Smith. Community Pharmacy

Primary Care/Community Based Service Palliative Care (Just in Case Medicines) Fylde and Wyre CCG Pete Smith. Community Pharmacy Service Specification No. 1. Service Commissioner Lead Provider Lead Primary Care/Community Based Service Palliative Care (Just in Case Medicines) Fylde and Wyre CCG Pete Smith Community Pharmacy Period

More information

Final. Andrew McMylor / Dr Nicola Jones

Final. Andrew McMylor / Dr Nicola Jones NHS Standard Contract - Service Specification Service Specification Service Final 24hour Ambulatory Blood Pressure Monitoring (24hrABPM) Commissioner Lead Lead Andrew McMylor / Dr Nicola Jones Jeremy Fenwick,

More information

Quality Standards for Enhanced Primary Care Services. Version 1.2

Quality Standards for Enhanced Primary Care Services. Version 1.2 Quality Standards for Enhanced Primary Care Services Version 1.2 September 2014 8831 September 2014 West Midlands Quality Review Service These Quality Standards may be reproduced and used freely by NHS

More information

Safer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS

Safer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS Safer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS Steve Chaplin describes the NPSA s anticoagulant patient safety alert and the measures it recommends for making the

More information

Anticoagulation Manager Training Day Plan

Anticoagulation Manager Training Day Plan Anticoagulation Manager Training Day Plan Versioning Author: Debbie Cuthbert/Emma Stubbs Reviewer(s): Debbie Cuthbert, Jim Holden Date Version Contents 22/10/2014 01 Initial draft day plan. 31/10/2014

More information

Alert. Patient safety alert. Actions that can make anticoagulant therapy safer. 28 March Action for the NHS and the independent sector

Alert. Patient safety alert. Actions that can make anticoagulant therapy safer. 28 March Action for the NHS and the independent sector Patient safety alert 18 Alert 28 March 2007 Immediate action Action Update Information request Ref: NPSA/2007/18 Actions that can make anticoagulant therapy safer Anticoagulants are one of the classes

More information

Enhanced service specification. Avoiding unplanned admissions: proactive case finding and patient review for vulnerable people

Enhanced service specification. Avoiding unplanned admissions: proactive case finding and patient review for vulnerable people Enhanced service specification Avoiding unplanned admissions: proactive case finding and patient review for vulnerable people 1 Enhanced service specification Avoiding unplanned admissions: proactive case

More information

Setting up an Anticoagulation Clinic in Primary Care. Contents

Setting up an Anticoagulation Clinic in Primary Care. Contents Setting up an Anticoagulation Clinic in Primary Care This paper aims to outline the decisions and practical steps needed to set up and run a successful anticoagulation clinic in a primary care setting.

More information

Community DVT Service. Phase 3: Anticoagulation at DVT Treatment Centres

Community DVT Service. Phase 3: Anticoagulation at DVT Treatment Centres Community DVT Service Quick Reference Guide Phase - Anticoagulation Phase : Anticoagulation at DVT Treatment Centres If a Patient has had a positive Ultrasound Scan they attend one of the DVT Treatment

More information

SCHEDULE 2 THE SERVICES

SCHEDULE 2 THE SERVICES SCHEDULE 2 THE SERVICES A. Service Specifications Service Specification. 001 Service Commissioner Lead Contracting Lead Provider Lead Period Teledermoscopy Service Dr Nicholas Rayner and Dr Andrew Yager

More information

Commissioning effective anticoagulation services for the future: A resource pack for commissioners

Commissioning effective anticoagulation services for the future: A resource pack for commissioners Commissioning effective anticoagulation services for the future: A resource pack for commissioners The development of this commissioning toolkit was supported by Bayer HealthCare. Bayer HealthCare paid

More information

SCHEDULE 2 THE SERVICES

SCHEDULE 2 THE SERVICES SCHEDULE 2 THE SERVICES A. Service Specifications Mandatory headings 1 4. Mandatory but detail for local determination and agreement Optional headings 5-7. Optional to use, detail for local determination

More information

Setting up the NOAC Service & Taking it to Primary Care

Setting up the NOAC Service & Taking it to Primary Care Setting up the NOAC Service & Taking it to Primary Care Satinder Bhandal Consultant Anticoagulation Pharmacist November 2015 Buckinghamshire Health Care NHS Trust Quiz 1. What is the most serious side

More information

West Midlands Strategic Clinical Network & Senate Improving the detection and management of Atrial Fibrillation in Primary Care

West Midlands Strategic Clinical Network & Senate Improving the detection and management of Atrial Fibrillation in Primary Care West Midlands Strategic Clinical Network & Senate Improving the detection and management of Atrial Fibrillation in Primary Care Good Practice Guide Improving the detection and management of Atrial Fibrillation

More information

INR Self Testing. Stephan Moll, MD Department of Medicine HEMOPHILIA AND THROMBOSIS CENTER UNIVERSITY OF NORTH CAROLINA

INR Self Testing. Stephan Moll, MD Department of Medicine HEMOPHILIA AND THROMBOSIS CENTER UNIVERSITY OF NORTH CAROLINA P A T I E N T I N F O R M A T I O N G U I D E INR Self Testing Stephan Moll, MD Department of Medicine HEMOPHILIA AND THROMBOSIS CENTER UNIVERSITY OF NORTH CAROLINA A Summary INR home testing devices are

More information

Oxfordshire Primary Care Commissioning Committee. Date of Meeting: 3 January 2017 Paper No: 9

Oxfordshire Primary Care Commissioning Committee. Date of Meeting: 3 January 2017 Paper No: 9 Oxfordshire Clinical Commissioning Group Oxfordshire Primary Care Commissioning Committee Date of Meeting: 3 January 2017 Paper No: 9 Title of Presentation: OCCG Primary Care Locally Commissioned Services

More information

Document ref. no: Trust Policy and Procedure PP(16)238 MANAGEMENT OF ADULT PATIENTS TREATED WITH ORAL ANTICOAGULANTS. Approved

Document ref. no: Trust Policy and Procedure PP(16)238 MANAGEMENT OF ADULT PATIENTS TREATED WITH ORAL ANTICOAGULANTS. Approved Document ref. no: Trust Policy and Procedure PP(16)238 MANAGEMENT OF ADULT PATIENTS TREATED WITH ORAL ANTICOAGULANTS For use in: For use by: For use for: Document owner: Status: West Suffolk NHS Foundation

More information

SCHEDULE 2 THE SERVICES

SCHEDULE 2 THE SERVICES SCHEDULE 2 THE SERVICES A. Service Specifications Mandatory headings 1 4. Mandatory but detail for local determination and agreement Optional headings 5-7.Optional to use, detail for local determination

More information

DRAFT Service Specification GP-led Urgent Treatment Centre (UTC) Service

DRAFT Service Specification GP-led Urgent Treatment Centre (UTC) Service DRAFT Service Specification GP-led Urgent Treatment Centre (UTC) Service Executive summary: The Cornwall Sustainability and Transformation Plan known as Shaping our Future will describe a new model of

More information

NPSA Alert 03: Reducing the harm caused by oral Methotrexate. Implementation Progress Report July Learning and Sharing

NPSA Alert 03: Reducing the harm caused by oral Methotrexate. Implementation Progress Report July Learning and Sharing NPSA Alert 03: Reducing the harm caused by oral Methotrexate Implementation Progress Report July 2006 Learning and Sharing CONTENTS Page 1 Background 3 2 Findings 4 Appendix 1 Summary of responses 6 Appendix

More information

East Lancashire DVT Local Enhanced Services (LES)

East Lancashire DVT Local Enhanced Services (LES) Agenda Item No: 6.5 REPORT TO: PRIMARY CARE COMMITTEE MEETING DATE: 13 September 2017 REPORT TITLE: SUMMARY OF REPORT: REPORT RECOMMENDATIONS: East Lancashire DVT Local Enhanced Services (LES) The paper

More information

Diagnostics Assessment Report (DAR) - Comments

Diagnostics Assessment Report (DAR) - Comments Diagnostics Assessment Report (DAR) - s Bradford District CCG 1. 1.1 Whilst the views of stakeholders wrt to NOACs varies widely, it is a fact that they have an important place in the pathway of care So

More information

Best Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland. patient CMP

Best Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland. patient CMP Best Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland patient CMP nurse doctor For further information relating to Nurse Prescribing please contact the Nurse

More information

Digital INR Monitoring A model of remote INR testing. Ian Dove, Tracy Murphy, Jeannie Hardy County Durham and Darlington NHS FT

Digital INR Monitoring A model of remote INR testing. Ian Dove, Tracy Murphy, Jeannie Hardy County Durham and Darlington NHS FT Digital INR Monitoring A model of remote INR testing Ian Dove, Tracy Murphy, Jeannie Hardy County Durham and Darlington NHS FT About NHS Health Call NHS Health Call is a digital health partnership between

More information

War on Warfarin: Integrating DOACs into your Anticoagulation Service

War on Warfarin: Integrating DOACs into your Anticoagulation Service War on Warfarin: Integrating DOACs into your Anticoagulation Service David DeiCicchi, Pharm.D, CACP Brigham and Women s Hospital September 30 th, 2016 Disclosures I have no financial conflict of interest

More information

Statement 2: Patients/carers are offered verbal and written information on VTE prevention as part of the admission process.

Statement 2: Patients/carers are offered verbal and written information on VTE prevention as part of the admission process. THROMBOSIS GROUP Venous thromboembolism (VTE) is a collective term referring to deep vein thrombosis (DVT) and pulmonary embolism (PE). VTE is defined by the following ICD-10 codes: I80.0-I80.3, I80.8-I80.9,

More information

Principles of Shared Care Protocols

Principles of Shared Care Protocols Principles of Shared Care Protocols 1 Robust shared care arrangements facilitate the safe transition of medicines for use in a specified condition between secondary and primary care clinicians with the

More information

Prescribing Quality Review Scheme (PQRS) 2016/17

Prescribing Quality Review Scheme (PQRS) 2016/17 Introduction: The Prescribing Quality Review Scheme (PQRS) has been designed to reflect the four key principles of medicines optimisation: Understanding and improving patient experience. Evidence based

More information

Specialised Services Service Specification: Inherited Bleeding Disorders

Specialised Services Service Specification: Inherited Bleeding Disorders Specialised Services Service Specification: Inherited Bleeding Disorders Document Author: Assistant Specialised Services Planner Cardiac and Cancer Specialised Services Planner Cancer and Blood Executive

More information

ATRIAL FIBRILLATION & STROKE INSIGHTS TOOL

ATRIAL FIBRILLATION & STROKE INSIGHTS TOOL ATRIAL FIBRILLATION & STROKE INSIGHTS TOOL CAN REAL WORLD/PUBLICALLY AVAILABLE DATA COUPLED WITH TTR DATA HELP THE NHS STOP STROKES? Andrzei Orlowski -Programme Development Lead for Health and Implementation

More information

THE SERVICES. A. Service Specifications (B1) Ian Diley (Suffolk County Council)

THE SERVICES. A. Service Specifications (B1) Ian Diley (Suffolk County Council) THE SERVICES A. Service Specifications (B1) Service Specification No. Service Early Supported Discharge for Stroke Patients v5.0 Commissioner Lead Dr Mark Lim, T Woor (Suffolk Stroke Review Project Board)

More information

Enhanced service specification. Avoiding unplanned admissions: proactive case finding and patient review for vulnerable people 2016/17

Enhanced service specification. Avoiding unplanned admissions: proactive case finding and patient review for vulnerable people 2016/17 Enhanced service specification Avoiding unplanned admissions: proactive case finding and patient review for vulnerable people 2016/17 NHS England INFORMATION READER BOX Directorate Medical Commissioning

More information

Review of Local Enhanced Services

Review of Local Enhanced Services Review of Local Enhanced Services 1. Background and context 1.1 CCGs are required to prepare for the phasing out of LESs by April 2014 by reviewing the existing LES portfolio and developing commissioning

More information

Service Specification: Immigration Removal Centre Mental Health Services. NHS England Publications Gateway Reference Number: 07038

Service Specification: Immigration Removal Centre Mental Health Services. NHS England Publications Gateway Reference Number: 07038 1 Service Specification: Immigration Removal Centre Mental Health Services August 2017 NHS England Publications Gateway Reference Number: 07038 Classification: Official 2 Service Specifications Mandatory

More information

Babylon Healthcare Services

Babylon Healthcare Services Babylon Healthcare Services Limited Babylon Healthcare Services Ltd. Inspection report 60 Sloane Avenue London SW3 3DD Tel: 0207 1000762 Website: www.babylonhealth.com Date of inspection visit: 4 July

More information

Service Specification

Service Specification Service Specification Minor Injuries Release: FINAL Date: 30/11/10 Author: Laura Smith Urgent Care Commissioning Manager NHS Derbyshire County Owner: Service Specification owner Owner s designation Owner

More information

How Pharmacies are supporting the move from Secondary to Primary Care. Peter Bainbridge, Director of Pharmacy,

How Pharmacies are supporting the move from Secondary to Primary Care. Peter Bainbridge, Director of Pharmacy, How Pharmacies are supporting the move from Secondary to Primary Care Peter Bainbridge, Director of Pharmacy, Alliance Boots Present in over 25 countries Over 116,000 employees 3,330 Health and Beauty

More information

A. Commissioning for Quality and Innovation (CQUIN)

A. Commissioning for Quality and Innovation (CQUIN) A. Commissioning for Quality and Innovation (CQUIN) CQUIN Table 1: Summary of goals Total fund available: 3,039,000 (estimated, based on 2015/16 baseline) Goal Number 1 2 3 4 5 Goal Name Description of

More information

Prescribing Policy between Nottinghamshire Commissioning Organisations and local providers of NHS Services

Prescribing Policy between Nottinghamshire Commissioning Organisations and local providers of NHS Services Prescribing Policy between Nottinghamshire Commissioning Organisations and local providers of NHS Services Document Purpose Version 2.2 To detail the specific contractual issues associated with prescribing

More information

Hospital Discharge and Transfer Guidance. Choice, Responsiveness, Integration & Shared Care

Hospital Discharge and Transfer Guidance. Choice, Responsiveness, Integration & Shared Care Hospital Discharge and Transfer Guidance Choice, Responsiveness, Integration & Shared Care Worcestershire Mental Health Partnership NHS Trust Information Reader Box Document Type: Document Purpose: Unique

More information

PROPOSAL TO UPDATE NEAR PATIENT TESTING ENHANCED SERVICE

PROPOSAL TO UPDATE NEAR PATIENT TESTING ENHANCED SERVICE PROPOSAL TO UPDATE NEAR PATIENT TESTING ENHANCED SERVICE 1.0 ACTION BY AWMSG: The All Wales Medicines Strategy Group (AWMSG) meeting held on 15 th December 2010 considered and approved the recommendations

More information

New Medicine Service (NMS) data definitions

New Medicine Service (NMS) data definitions New Medicine Service (NMS) data definitions December 2013 The data reported to NHS England Area Teams (ATs) is designed to provide useful information to commissioners. The reporting periods for the New

More information

National Enhanced Service (NES) for Minor Injury Services

National Enhanced Service (NES) for Minor Injury Services National Enhanced Service (NES) for Minor Injury Services Service Level Agreement PRACTICE Contents: 1. Finance Details 2. Signature Sheet 3. Service Aims 4. Criteria 5. Ongoing Measurement & Evaluation

More information

GOVERNING BODY REPORT

GOVERNING BODY REPORT GOVERNING BODY REPORT Date of Governing Body Meeting: Title of Report: Key Messages: Finance, Performance and Commissioning Committee Report At the end of September 2017 we have reported an inyear deficit

More information

Improving sexual health is a key national public health priority (Healthy Lives, Healthy People, Department of Health, 2010).

Improving sexual health is a key national public health priority (Healthy Lives, Healthy People, Department of Health, 2010). SERVICE SPECIFICATION Service Specification No. Service name Pharmacy Enhanced Services - chlamydia treatment Plymouth City Council Lead Laura Juett, Public Health Policy and Service Development Manager

More information

Oxfordshire Anticoagulation Service. Important information about anticoagulation with vitamin K antagonists Information for patients

Oxfordshire Anticoagulation Service. Important information about anticoagulation with vitamin K antagonists Information for patients Oxfordshire Anticoagulation Service Important information about anticoagulation with vitamin K antagonists Information for patients Page 2 Your information Name:... Address:......... or patient stickie

More information

MANAGING THE INR CLINIC : IJN EXPERIENCE

MANAGING THE INR CLINIC : IJN EXPERIENCE MANAGING THE INR CLINIC : IJN EXPERIENCE Anticoagulation Workshop 21 st August 2015 KAMALESWARY ARUMUGAM PRINCIPAL PHARMACIST LEE LEE HO1 NURSE MENTOR, INR CLINIC HISTORY & OVERVIEW OF THE INR CLINIC HISTORY

More information

NHS England (Wessex) Clinical Senate and Strategic Networks. Accountability and Governance Arrangements

NHS England (Wessex) Clinical Senate and Strategic Networks. Accountability and Governance Arrangements NHS England (Wessex) Clinical Senate and Strategic Networks Accountability and Governance Arrangements Version 6.0 Document Location: This document is only valid on the day it was printed. Location/Path

More information

SCHEDULE 2 THE SERVICES

SCHEDULE 2 THE SERVICES SCHEDULE 2 THE SERVICES A. Service Specifications Service Specification No. Service E08/S/b Neonatal Intensive Care Transport Commissioner Lead Provider Lead Period Date of Review 12 Months 1. Population

More information

HOME TREATMENT SERVICE OPERATIONAL PROTOCOL

HOME TREATMENT SERVICE OPERATIONAL PROTOCOL HOME TREATMENT SERVICE OPERATIONAL PROTOCOL Document Type Unique Identifier To be set by Web and Systems Development Team Document Purpose This protocol sets out how Home Treatment is provided by Worcestershire

More information

Any Qualified Provider: your questions answered

Any Qualified Provider: your questions answered Any Qualified Provider: your questions answered September 8, 2011 These answers cover a range of questions about the detail of Any Qualified Provider on integrated care, competition and procurement, liability

More information

SPONSORSHIP AND JOINT WORKING WITH THE PHARMACEUTICAL INDUSTRY

SPONSORSHIP AND JOINT WORKING WITH THE PHARMACEUTICAL INDUSTRY SPONSORSHIP AND JOINT WORKING WITH THE PHARMACEUTICAL INDUSTRY 1 SUMMARY This document sets out Haringey Clinical Commissioning Group policy and advice to employees on sponsorship and joint working with

More information

COMMISSIONING SUPPORT PROGRAMME. Standard operating procedure

COMMISSIONING SUPPORT PROGRAMME. Standard operating procedure NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE COMMISSIONING SUPPORT PROGRAMME Standard operating procedure April 2018 1. Introduction The Commissioning Support Programme (CSP) at NICE supports the

More information

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section. TITLE MEDICATION ORDERS SCOPE Provincial APPROVAL AUTHORITY Clinical Operations Executive Committee SPONSOR Provincial Medication Management Committee PARENT DOCUMENT TITLE, TYPE AND NUMBER Medication

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE 1 Guideline title SCOPE Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes 1.1 Short title Medicines

More information

#NeuroDis

#NeuroDis Each and Every Need A review of the quality of care provided to patients aged 0-25 years old with chronic neurodisability, using the cerebral palsies as examples of chronic neurodisabling conditions Recommendations

More information

GP Cover of Nursing, Residential, Extra Care and Intermediate Care Homes. Camden Clinical Commissioning Group. Care Home LES Spec v1

GP Cover of Nursing, Residential, Extra Care and Intermediate Care Homes. Camden Clinical Commissioning Group. Care Home LES Spec v1 Local Enhanced Service Clinical Lead Commissioner Reporting Mechanism/Frequency Payment Frequency Payment Contact This Version GP Cover of Nursing, Residential, Extra Care and Intermediate Care Homes Dr

More information

CCG Policy for Working with the Pharmaceutical Industry

CCG Policy for Working with the Pharmaceutical Industry CCG Policy for Working with the Pharmaceutical Industry 1. Introduction Medicines are the most frequently and widely used NHS treatment and account for over 12% of NHS expenditure. The Pharmaceutical Industry

More information

NHS Standard Contract (Accountable Care Models) [(fully integrated)] [(partially integrated)] 2017/18 and 2018/19 Service Conditions

NHS Standard Contract (Accountable Care Models) [(fully integrated)] [(partially integrated)] 2017/18 and 2018/19 Service Conditions NHS Standard Contract (Accountable Care Models) [(fully integrated)] [(partially integrated)] 2017/18 and 2018/19 Service Conditions NHS Standard Contract (Accountable Care Models) 2017/18 and 2018/19

More information

Medicines Governance Service to Care Homes (Care Home Service)

Medicines Governance Service to Care Homes (Care Home Service) Medicines Governance Service to Care Homes (Care Home Service) Locally Enhanced Service Authors: Ruth Buchan, Senior Pharmacist Medicines Management 4th Floor F Mill Dean Clough Halifax HX3 5AX Tel-01422

More information

Commissioning Policy

Commissioning Policy Commissioning Policy Consultant to Consultant Referrals Version 6.0 December 2017 Name of Responsible Board / Committee for Ratification: North Staffordshire CCG Stoke on Trent CCG Date Issued: November

More information

Accreditation Program: Long Term Care

Accreditation Program: Long Term Care ccreditation Program: Long Term are National Patient Safety Goals indicates scoring category ; indicates scoring category ; indicates situational decision rules apply; indicates 2009 The Joint ommission

More information

Care Home support and medicines optimisation: Community Pharmacy National Enhanced Service

Care Home support and medicines optimisation: Community Pharmacy National Enhanced Service Care Home support and medicines optimisation: Community Pharmacy National Enhanced Service 1 1. Introduction Back in 2006 the National Service Framework for Older People in Wales 1 highlighted the problem

More information

Literature review: pharmaceutical services for prisoners

Literature review: pharmaceutical services for prisoners Author: Rosemary Allgeier, Principal Pharmacist in Public Health. Date: 08 October 2012 Version: 1a Publication and distribution: NHS Wales (intranet and internet) Public Health Wales (intranet and internet)

More information

Community Pharmacy Emergency Hormonal Contraception Service

Community Pharmacy Emergency Hormonal Contraception Service Community Pharmacy Emergency Hormonal Contraception Service Author: Peer Reviews: Produced January 2010 Review date- April 2013 Ruth Buchan Julie Landale Medicines Management 4th Floor F Mill Dean Clough

More information

Delivering the QIPP programme: making existing services improve patient outcomes

Delivering the QIPP programme: making existing services improve patient outcomes Delivering the QIPP programme: making existing services improve patient outcomes Produced by Glyn Davies MP, Chair All-Party Parliamentary Group on AF in association with the Atrial Fibrillation Association

More information

Putting Barnsley People First. Quality and Patient Safety Committee Terms of Reference

Putting Barnsley People First. Quality and Patient Safety Committee Terms of Reference Putting Barnsley People First Quality and Patient Safety Committee Terms of Reference 1. Introduction NHS Barnsley Clinical Commissioning Group Quality and Patient Safety Committee 1.1 The Clinical Commissioning

More information

NHS North Norfolk and NHS South Norfolk General Practice Forward View Operational Plan

NHS North Norfolk and NHS South Norfolk General Practice Forward View Operational Plan NHS North Norfolk and NHS South Norfolk General Practice Forward View Operational Plan Ensuring high quality healthcare services for the people of North and South Norfolk 1 VERSION CONTROL Document Purpose:

More information

SCHEDULE 2 THE SERVICES Service Specifications

SCHEDULE 2 THE SERVICES Service Specifications SCHEDULE 2 THE SERVICES Service Specifications Service Specification No Service ParaDoc Commissioner City and Hackney CCG Commissioner Lead Leah Herridge Provider CHUHSE Provider Lead Date of Review September

More information

ANTICOAGULATION CLINIC

ANTICOAGULATION CLINIC ANTICOAGULATION CLINIC COMMUNITY MEMORIAL HOSPITAL AND CLINIC BETTY MEIGHAN, RN, BSN SUMNER, IOWA PROGRAM INITIATION Provider request for patient benefit Time factor for physicians in office Significant

More information

This SLA covers an enhanced service for care homes for older people and not any other care category of home.

This SLA covers an enhanced service for care homes for older people and not any other care category of home. Care Homes for Older People Service Level Agreement 2016-2019 All practices are expected to provide essential and those additional services they are contracted to provide to all their patients. This service

More information

Local Enhanced Service Agreement 1 July March 2016

Local Enhanced Service Agreement 1 July March 2016 Local Enhanced Service Agreement 1 July 2013 31 March 2016 Recognition and Management of People with Dementia and their Family/Carers in General Practices in Bristol Agreement between NHS Bristol Clinical

More information

Medicines Reconciliation: Standard Operating Procedure

Medicines Reconciliation: Standard Operating Procedure Clinical Medicines Reconciliation: Standard Operating Procedure Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation

More information

Support for Anticoagulation UK with this project has been provided by MHP Health, whose services were paid for by Bayer. Bayer has reviewed the

Support for Anticoagulation UK with this project has been provided by MHP Health, whose services were paid for by Bayer. Bayer has reviewed the Support for Anticoagulation UK with this project has been provided by MHP Health, whose services were paid for by Bayer. Bayer has reviewed the contents of the report to ensure compliance with the ABPI

More information

CLINICAL AUDIT. The Safe and Effective Use of Warfarin

CLINICAL AUDIT. The Safe and Effective Use of Warfarin CLINICAL AUDIT The Safe and Effective Use of Warfarin Valid to May 2019 bpac nz better medicin e Background Warfarin is the medicine most frequently associated with adverse drug reactions in New Zealand.

More information

Prevention and Treatment of Venous Thromboembolism (VTE) Policy

Prevention and Treatment of Venous Thromboembolism (VTE) Policy CONTROLLED DOCUMENT Prevention and Treatment of Venous Thromboembolism (VTE) Policy CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Version Number: 3 Controlled Document Sponsor: Controlled

More information

TESTING TIMES TO COME? AN EVALUATION OF PATHOLOGY CAPACITY IN ENGLAND NOVEMBER 2016

TESTING TIMES TO COME? AN EVALUATION OF PATHOLOGY CAPACITY IN ENGLAND NOVEMBER 2016 TESTING TIMES TO COME? AN EVALUATION OF PATHOLOGY CAPACITY IN ENGLAND NOVEMBER 2016 EXECUTIVE SUMMARY Whilst cancer survival is at its highest ever level, our health services are under considerable pressure.

More information

Integrated heart failure service working across the hospital and the community

Integrated heart failure service working across the hospital and the community Integrated heart failure service working across the hospital and the community Lynne Ruddick Professional Lead (South) British Heart Foundation 31st October 2017 Heart Failure is an epidemic. NICE has

More information

Fifth Annual Audit of Acute NHS Trusts VTE Policies

Fifth Annual Audit of Acute NHS Trusts VTE Policies All-Party Parliamentary Thrombosis Group Fifth Annual Audit of Acute NHS Trusts VTE Policies Launched at a Meeting in the House of Commons Thursday 24 th Hosted by Andrew Gwynne MP and Michael McCann MP

More information

The Management and Control of Hospital Acquired Infection in Acute NHS Trusts in England

The Management and Control of Hospital Acquired Infection in Acute NHS Trusts in England Report by the Comptroller and Auditor General The Management and Control of Hospital Acquired Infection in Acute NHS Trusts in England Ordered by the House of Commons to be printed 14 February 2000 LONDON:

More information

Liberating the NHS: No decision about me, without me Further consultation on proposals to shared decision-making

Liberating the NHS: No decision about me, without me Further consultation on proposals to shared decision-making Liberating the NHS: No decision about me, without me Further consultation on proposals to shared decision-making Royal Pharmaceutical Society response The Royal Pharmaceutical Society (RPS) is the professional

More information

Managing medicines in care homes

Managing medicines in care homes Managing medicines in care homes http://www.nice.org.uk/guidance/sc/sc1.jsp Published: 14 March 2014 Contents What is this guideline about and who is it for?... 5 Purpose of this guideline... 5 Audience

More information

Unlicensed Medicines Policy Document

Unlicensed Medicines Policy Document Unlicensed Medicines Policy Document Effective: February 2002 (Intranet 2006) Review date: February 2007 A. Introduction In order to ensure that medicines are safe and effective the manufacture and sale

More information

3. The requirements for taking part in the ES are as follows:

3. The requirements for taking part in the ES are as follows: Enhanced Service Specification Learning disabilities health check scheme Background and purpose 1. This enhanced service (ES) is designed to encourage practices to identify all patients aged 14 and over

More information

This controlled document shall not be copied in part or whole without the express permission of the author or the author s representative.

This controlled document shall not be copied in part or whole without the express permission of the author or the author s representative. This document is also available in large print and other formats and languages, upon request. Please call NHS Grampian Corporate Communications on (01224) 551116 or (01224) 552245. This controlled document

More information

AHSN AF Programme The Results So Far. Kate Mackay AF Programme Manager

AHSN AF Programme The Results So Far. Kate Mackay AF Programme Manager AHSN AF Programme The Results So Far Kate Mackay AF Programme Manager Atrial Fibrillation Programme Aim To decrease the number of AF-related strokes by: Decreasing the prevalence gap and finding the missing

More information

Rights and Responsibilities of Patients and Family Members

Rights and Responsibilities of Patients and Family Members Rights and Responsibilities of Patients and Family Members Certificado pela Joint Commission International Padrão Internacional de qualidade em atendimento médico e hospitalar. Rights and Responsibilities

More information

Introduction of Clinical Nurse Specialists to the Leeds Anticoagulation Service- Changing Perceptions

Introduction of Clinical Nurse Specialists to the Leeds Anticoagulation Service- Changing Perceptions Introduction of Clinical Nurse Specialists to the Leeds Anticoagulation Service- Changing Perceptions Karen Hodgkinson RN, BSc (Hons) Clinical Nurse Specialist/ Team Leader DAWN USER GROUP- Monday 3rd

More information